Management of high blood pressure in African Americans - Consensus statement of the hypertension in African Americans Working Group of the International Society on Hypertension in Blacks

被引:287
作者
Douglas, JG
Bakris, GL
Epstein, M
Ferdinand, KC
Ferrario, C
Flack, JM
Jamerson, KA
Jones, WE
Haywood, J
Maxey, R
Ofili, EO
Sanders, E
Schiffrin, EL
Sica, DA
Sowers, JR
Vidt, DG
机构
[1] Case Western Reserve Univ, Dept Med, Sch Med, Cleveland, OH 44106 USA
[2] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
[3] Univ Miami, Sch Med, Miami, FL 33152 USA
[4] Heartbeats Life Ctr, New Orleans, LA USA
[5] Wake Forest Univ, Sch Med, Hypertens & Vasc Dis Ctr, Winston Salem, NC 27109 USA
[6] Wayne State Univ, Sch Med, Detroit, MI USA
[7] Univ Michigan, Hlth Syst, Ann Arbor, MI 48109 USA
[8] S Texas Vet Hlth Syst, San Antonio, TX USA
[9] Univ So Calif, Med Ctr, Los Angeles, CA USA
[10] Natl Med Assoc Board Trustees, Los Angeles, CA USA
[11] Morehouse Sch Med, Atlanta, GA 30310 USA
[12] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
[13] Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada
[14] Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23298 USA
[15] SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA
[16] Cleveland Clin Fdn, Cleveland, OH 44195 USA
关键词
D O I
10.1001/archinte.163.5.525
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this consensus statement is to offer primary care providers (including physicians, nurse practitioners, and physician assistants) a practical, evidence-based clinical tool for achieving blood pressure goals in African American patients. The need for specific recommendations for African Americans is highlighted by compelling evidence of a higher prevalence of hypertension and poorer cardiovascular and renal outcomes in this group than in white Americans. African Americans have disturbingly higher rates of cardiovascular mortality, stroke, hypertension-related heart disease, congestive heart failure, type 2 diabetes mellitus, hypertensive nephropathy, and end-stage renal disease (ESRD).
引用
收藏
页码:525 / 541
页数:17
相关论文
共 132 条
[71]   Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension [J].
Kochar, M ;
Guthrie, R ;
Triscari, J ;
Kassler-Taub, K ;
Reeves, RA .
AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (08) :797-805
[72]   Dietary electrolytes and blood pressure - A statement for healthcare professionals from the American Heart Association Nutrition Committee [J].
Kotchen, TA ;
McCarron, DA .
CIRCULATION, 1998, 98 (06) :613-617
[73]  
Krauss RM, 2000, CIRCULATION, V102, P2284
[74]   Are calcium antagonists effective in preventing complications of hypertension and progression of renal disease? [J].
Laing, C ;
Unwin, RJ .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2000, 9 (05) :489-495
[75]  
Law CM, 1996, J HYPERTENS, V14, P935
[76]   Appointment attendance, pill counts, and achievement of goal blood pressure in the African American Study of Kidney Disease and Hypertension Pilot Study [J].
Lee, JY ;
Greene, PG ;
Douglas, M ;
Grim, C ;
Kirk, KA ;
Kusek, JW ;
Milligan, S ;
Smith, DE ;
Whelton, PK .
CONTROLLED CLINICAL TRIALS, 1996, 17 (04) :S34-S39
[77]   Black-white inequalities in mortality and life expectancy, 1933-1999: Implications for healthy people 2010 [J].
Levine, RS ;
Foster, JE ;
Fullilove, RE ;
Fullilove, MT ;
Briggs, NC ;
Hull, PC ;
Husaini, BA ;
Hennekens, CH .
PUBLIC HEALTH REPORTS, 2001, 116 (05) :474-483
[78]  
LEVY D, 1990, NEW ENGL J MED, V0322
[79]   Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes [J].
Lewis, EJ ;
Hunsicker, LG ;
Clarke, WR ;
Berl, T ;
Pohl, MA ;
Lewis, JB ;
Ritz, E ;
Atkins, RC ;
Rohde, R ;
Raz, I .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :851-860
[80]   THE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON DIABETIC NEPHROPATHY [J].
LEWIS, EJ ;
HUNSICKER, LG ;
BAIN, RP ;
ROHDE, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (20) :1456-1462